Results 261 to 270 of about 78,184 (307)

Potential of small-molecule targeted drugs in combination with CAR-T cell therapy for hematologic lymphomas. [PDF]

Front Immunol
Tang W, Yu S.
europepmc   +1 more source

BTK-Inhibitor Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Targeting Elimination of Autoreactive BAFFR^high B Cells. [PDF]

Int J Mol Sci
Zhang Y, Wen J, Jiang B, Jiang H, Xu J, Tao J.   +5 more
europepmc   +1 more source

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.

Blood
Brown JR, Nguyen B, Desikan SP, Won H, Tantawy SI, McNeely SC, Marella N, Randeria HS, Hanson LM, Parker A, Botelho SC, Woyach JA, Patel K, Tam CS, Eyre TA, Cheah CY, Shah NN, Ghia P, Jurczak W, Balbas M, Nair B, Abada P, Wang C, Wang D, Roeker LE, Gandhi V, Wierda WG.   +26 more
europepmc   +1 more source

Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B-cell malignancies. [PDF]

ESMO Open
Zhu J, Li J, Tam CS, Wang L, Xu J, Zhang J, Khanna P, Qiu L.   +7 more
europepmc   +1 more source

Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: A LIFE-BTK Pharmacokinetics Substudy. [PDF]

J Soc Cardiovasc Angiogr Interv
Lee JK, Pin R, Jansen S, Mehrle AP, Khatib Y, Krishnan P, DeRubertis BG, Varcoe RL, Popiel A, Pingle SC, Ruster K, Parikh SA.   +11 more
europepmc   +1 more source

Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury. [PDF]

Nat Immunol
Naouar I, Pangan A, Zuo M, Raza SA, Champagne-Jorgensen K, Patel J, Wang A, Pu A, Ward L, Ahn JSY, Sayeed FN, Zhu J, Pössnecker E, Spring S, Sled JG, Cenni B, Nuesslein-Hildesheim B, Browning JL, Pröbstel AK, Reich DS, Gommerman JL, Ramaglia V.   +21 more
europepmc   +1 more source

Prospects and advances of PROTAC in the treatment of hematologic malignancies. [PDF]

Exp Hematol Oncol
Wang X, Zhang M, Mei H.
europepmc   +1 more source

RNA Sequencing Addresses a 5' UTR Variant Leading to X-Linked Agammaglobulinemia and Broader Immune Dysregulation. [PDF]

J Clin Immunol
Xu K, Zhang B, Zhao S, Zhang Y, Wu N, Shen M, Zeng X.   +6 more
europepmc   +1 more source

Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBCL. [PDF]

Ann Hematol
Lu J, Zhang Y, Ye X, Shi J, Lin Q, Li R, Du X, Cao L, Tian T, Wang J, Xia Y, Liu H, Cheng Y, Fan L, Shen H, Wang S.   +15 more
europepmc   +1 more source